Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Lifecore Biomedical, Inc.
The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.
www.lifecore.comAI Executive Summary
AI-powered analysis of 8-K filing content
Lifecore Biomedical, Inc. entered into a merger agreement with Lifecore Inc. and Hazel Merger Sub, Inc. on September 27, 2026, whereby Lifecore Biomedical will become a wholly owned subsidiary of Lifecore Inc., backed by Webster Equity Partners. This strategic transaction marks a significant corporate restructuring in the biopharmaceutical sector.
Key Takeaways
Lifecore Biomedical agreed to merge with Lifecore Inc., with Hazel Merger Sub serving as the acquisition vehicle
Webster Equity Partners is the financial sponsor behind Lifecore Inc., indicating private equity involvement
2 more takeaways
Filing Overview
What This Means
Lifecore Biomedical, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.